Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-FN, L19-131 I Vector   (CAT#: GTVCR-WQ1680MR)

This product GTVCR-WQ1680MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting FN. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_001306129.2
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 2335
UniProt ID P02751
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-FN, L19-131 I Vector (GTVCR-WQ1680MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ747MR IVTScrip™ pT7-VEE-mRNA-Anti-CTLA4, BMS-734016 Vector Vector BMS-734016
GTVCR-WQ2217MR IVTScrip™ pSP6-VEE-mRNA-Anti-PCSK9, PF-05335810 Vector Vector PF-05335810
GTVCR-WQ1583MR IVTScrip™ pT7-VEE-mRNA-Anti-KIR3DL2, IPH4102 Vector Vector IPH4102
GTVCR-WQ744MR IVTScrip™ pT7-VEE-mRNA-Anti-TNFRSF9, BMS-663513 Vector Vector BMS-663513
GTVCR-WQ2319MR IVTScrip™ pT7-VEE-mRNA-Anti-CD3E&MS4A1, REGN-1979 Vector Vector REGN-1979
GTVCR-WQ2672MR IVTScrip™ pT7-VEE-mRNA-Anti-Felcat IL31, ZTS-00521505 Vector Vector ZTS-00521505
GTVCR-WQ270MR IVTScrip™ pSP6-VEE-mRNA-Anti-BMP10&GDF2, ACE-041 Vector Vector ACE-041
GTVCR-WQ1333MR IVTScrip™ pSP6-VEE-mRNA-Anti-ICOS, GSK-3359609 Vector Vector GSK-3359609
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.